Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Fengjiao Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5068-1906; OpenAlex author ID A5115602705. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer. Co-author DOI 10.1186/s12920-021-01043-5↗
  2. Natural Compound Methyl Protodioscin Suppresses Proliferation and Inhibits Glycolysis in Pancreatic Cancer. Co-author DOI 10.1155/2018/7343090↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhen Chen · 2 shared papers, 2018–2021 · strength 0.23
  2. Chien‐shan Cheng · 2 shared papers, 2018–2021 · strength 0.23
  3. Yanhua Jing · 1 shared paper, 2021 · strength 0.16
  4. Zhangqi Cao · 1 shared paper, 2021 · strength 0.16
  5. Juying Jiao · 1 shared paper, 2021 · strength 0.16
  6. Huifeng Gao · 1 shared paper, 2018 · strength 0.07
  7. Hao Chen · 1 shared paper, 2018 · strength 0.07
  8. Chao Qu · 1 shared paper, 2018 · strength 0.07
  9. Haifeng Chen · 1 shared paper, 2018 · strength 0.07
  10. Zhiqiang Meng · 1 shared paper, 2018 · strength 0.07
  11. Lianyu Chen · 1 shared paper, 2018 · strength 0.07
  12. Luming Liu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.